LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3807 | 3769 | 1.0099 | 1.0140 |
Hs 578T | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3666 | 3846 | 0.9533 | 0.9437 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 658 | 3661 | 3846 | 0.9519 | 0.9419 |
Hs 578T | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 658 | 4134 | 3846 | 1.0749 | 1.0904 |
BT-20 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3950 | 3769 | 1.0481 | 1.0678 |
BT-20 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3918 | 3769 | 1.0395 | 1.0557 |
BT-20 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3972 | 3769 | 1.0539 | 1.0760 |
Hs 578T | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 658 | 1085 | 3846 | 0.2823 | 0.1341 |
BT-20 | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3436 | 3769 | 0.9116 | 0.8753 |
BT-20 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3026 | 3769 | 0.8028 | 0.7218 |
BT-20 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 1423 | 3769 | 0.3775 | 0.1219 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3556 | 3846 | 0.9247 | 0.9092 |
BT-20 | Mitoxantrone | 0.04 | uM | LJP5 | 72 | hr | 1097 | 1459 | 3769 | 0.3872 | 0.1356 |
Hs 578T | AZD-6482 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3702 | 3846 | 0.9627 | 0.9550 |
BT-20 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3053 | 3769 | 0.8101 | 0.7321 |
Hs 578T | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 658 | 2831 | 3846 | 0.7361 | 0.6816 |
BT-20 | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 1097 | 1404 | 3769 | 0.3725 | 0.1148 |
Hs 578T | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 658 | 2131 | 3846 | 0.5541 | 0.4620 |
Hs 578T | AZD8330 | 0.04 | uM | LJP5 | 72 | hr | 658 | 1041 | 3846 | 0.2707 | 0.1201 |
Hs 578T | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 658 | 1200 | 3846 | 0.3120 | 0.1700 |
BT-20 | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 3292 | 3769 | 0.8734 | 0.8214 |
BT-20 | PIK-93 | 0.04 | uM | LJP5 | 72 | hr | 1097 | 3895 | 3769 | 1.0335 | 1.0472 |
BT-20 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1097 | 724 | 3769 | 0.1921 | -0.1397 |
MCF 10A | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 10370 | 10605 | 0.9779 | 0.9757 |
MCF 10A | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 962 | 9767 | 10605 | 0.9210 | 0.9131 |